Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial

被引:49
作者
Claassen, Y. H. M. [1 ]
Hartgrink, H. H. [1 ]
Dikken, J. L. [1 ]
de Steur, W. O. [1 ]
van Sandick, J. W. [2 ]
van Grieken, N. C. T. [3 ]
Cats, A. [4 ]
Trip, A. K. [5 ]
Jansen, E. P. M. [5 ]
Kranenbarg, W. M. Meershoek-Klein [1 ]
Braak, J. P. B. M. [1 ]
Putter, H. [6 ]
Henegouwen, M. I. van Berge [7 ]
Verheij, M. [5 ]
van de Velde, C. J. H. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Surg Oncol, POB 9600, NL-2300 RC Leiden, Netherlands
[2] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Surg Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pathol, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands
[4] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Gastrointestinal Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[5] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Med Stat, POB 9600, NL-2300 RC Leiden, Netherlands
[7] Acad Med Ctr, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源
EJSO | 2018年 / 44卷 / 05期
关键词
Gastric cancer surgery; Surgical morbidity; Surgical mortality; TOTAL GASTRECTOMY; POSTOPERATIVE COMPLICATIONS; RISK-FACTORS; ANASTOMOTIC LEAKAGE; SURVIVAL; SURGERY; BENEFIT; ADENOCARCINOMA; DISSECTION; SARCOPENIA;
D O I
10.1016/j.ejso.2018.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In order to determine the optimal combination of perioperative chemotherapy and che-moradiotherapy for Western patients with advanced resectable gastric cancer, the international multi centre CRITICS trial (ChemoRadiotherapy after Induction chemotherapy In Cancer of the Stomach) was initiated. In this trial, patients with resectable gastric cancer were randomised before start of treatment between adjuvant chemotherapy or adjuvant chemoradiotherapy following neoadjuvant chemotherapy plus gastric cancer resection. The purpose of this study was to report on surgical morbidity and mortality in this trial, and to identify factors associated with surgical morbidity. Methods: Patients who underwent a gastrectomy with curative intent were selected. Logistic regression analyses were used to assess risk factors for developing postoperative complications. Results: Between 2007 and 2015, 788 patients were included in the CRITICS trial, of whom 636 patients were eligible for current analyses. Complications occurred in 296 patients (47%). Postoperative mortality was 2.2% (n = 14). Complications due to anastomotic leakage was cause of death in 5 patients. Failure to complete preoperative chemotherapy (OR = 2.09, P = 0.004), splenectomy (OR = 2.82, P = 0.012), and male sex (OR = 1.55, P = 0.020) were associated with a greater risk for postoperative complications. Total gastrectomy and oesophago-cardia resection were associated with greater risk for morbidity compared with subtotal gastrectomy (OR = 1.88, P = 0.001 and OR = 1.89, P = 0.038). Conclusion: Compared to other Western studies, surgical morbidity in the CRITICS trial was slightly higher whereas mortality was low. Complications following anastomotic leakage was the most important factor for postoperative mortality. Important proxies for developing postoperative complications were failure to complete preoperative chemotherapy, splenectomy, male sex, total gastrectomy, and oesophago-cardia resection. (C) 2018 Published by Elsevier Ltd.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 29 条
[1]   Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database [J].
Bartlett, Edmund K. ;
Roses, Robert E. ;
Kelz, Rachel R. ;
Drebin, Jeffrey A. ;
Fraker, Douglas L. ;
Karakousis, Giorgos C. .
SURGERY, 2014, 156 (02) :298-304
[2]   RANDOMIZED COMPARISON OF MORBIDITY AFTER D1 AND D2 DISSECTION FOR GASTRIC-CANCER IN 996 DUTCH PATIENTS [J].
BONENKAMP, JJ ;
SONGUN, I ;
HERMANS, J ;
SASAKO, M ;
WELVAART, K ;
PLUKKER, JTM ;
VANELK, P ;
OBERTOP, H ;
GOUMA, DJ ;
TAAT, CW ;
VANLANSCHOT, J ;
MEYER, S ;
DEGRAAF, PW ;
VONMEYENFELDT, MF ;
TILANUS, H ;
VANDEVELDE, CJH .
LANCET, 1995, 345 (8952) :745-748
[3]   Gastric cancer:: which patients benefit from systematic lymphadenectomy? [J].
Bösing, NM ;
Goretzki, PE ;
Röher, HD .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (05) :498-505
[4]   Subtotal versus total gastrectomy for gastric cancer -: Five-year survival rates in a multicenter randomized Italian trial [J].
Bozzetti, F ;
Marubini, E ;
Bonfanti, G ;
Miceli, R ;
Piano, C ;
Gennari, L .
ANNALS OF SURGERY, 1999, 230 (02) :170-178
[5]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[6]   Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].
Cuschieri, A ;
Fayers, P ;
Fielding, J ;
Craven, J ;
Bancewicz, J ;
Joypaul, V ;
Cook, P .
LANCET, 1996, 347 (9007) :995-999
[7]   Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer [J].
Degiuli, M. ;
Sasako, M. ;
Ponti, A. .
BRITISH JOURNAL OF SURGERY, 2010, 97 (05) :643-649
[8]   Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) [J].
Dikken, Johan L. ;
van Sandick, Johanna W. ;
Swellengrebel, H. A. Maurits ;
Lind, Pehr A. ;
Putter, Hein ;
Jansen, Edwin P. M. ;
Boot, Henk ;
van Grieken, Nicole C. T. ;
van de Velde, Cornelis J. H. ;
Verheij, Marcel ;
Cats, Annemieke .
BMC CANCER, 2011, 11
[9]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[10]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386